$4.85 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | GLAUKOS CORPnote 2.750% 6/1 | $324,465,000 | -9.6% | 271,752,000 | +0.7% | 6.69% | -16.6% | |
| NUVALENT INC | $262,264,000 | -2.4% | 19,341,024 | 0.0% | 5.41% | -9.9% | ||
| VTRS | VIATRIS INC | $216,454,000 | -3.8% | 20,673,700 | 0.0% | 4.46% | -11.2% | |
| AHCO | Sell | ADAPTHEALTH CORP | $201,160,000 | +7.7% | 11,150,797 | -4.3% | 4.15% | -0.6% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $196,199,000 | +26.2% | 2,012,714 | +21.4% | 4.05% | +16.5% |
| INVITAE CORPnote 2.000% 9/0 | $163,025,000 | -4.0% | 206,873,000 | 0.0% | 3.36% | -11.4% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $133,036,000 | -6.2% | 157,390,000 | 0.0% | 2.74% | -13.5% | ||
| New | IONIS PHARMACEUTICALS INCnote 4/0 | $116,991,000 | – | 127,800,000 | +100.0% | 2.41% | – | |
| NATERA INCnote 2.250% 5/0 | $111,924,000 | -6.9% | 90,638,000 | 0.0% | 2.31% | -14.1% | ||
| SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $111,766,000 | -3.8% | 88,657,000 | 0.0% | 2.30% | -11.2% | ||
| BIIB | New | BIOGEN INCcall | $101,970,000 | – | 500,000 | +100.0% | 2.10% | – |
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $100,380,000 | -19.0% | 52,500,000 | 0.0% | 2.07% | -25.3% | ||
| SILK | Buy | SILK RD MED INC | $97,412,000 | +9.5% | 2,676,891 | +24.3% | 2.01% | +1.1% |
| Buy | TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $97,174,000 | +21.9% | 144,516,000 | +34.0% | 2.00% | +12.4% | |
| GILD | Buy | GILEAD SCIENCES INC | $95,969,000 | +110.9% | 1,552,639 | +102.8% | 1.98% | +94.6% |
| NUVASIVE INCnote 1.000% 6/0 | $93,615,000 | -2.9% | 96,966,000 | 0.0% | 1.93% | -10.4% | ||
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $84,967,000 | -15.8% | 81,600,000 | 0.0% | 1.75% | -22.3% | ||
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $82,200,000 | +58.9% | 6,250,964 | +12.0% | 1.70% | +46.5% |
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $76,456,000 | -6.4% | 51,885,000 | 0.0% | 1.58% | -13.7% | ||
| NUVASIVE INCnote 0.375% 3/1 | $71,655,000 | -5.9% | 80,000,000 | 0.0% | 1.48% | -13.2% | ||
| INSMED INCnote 1.750% 1/1 | $70,460,000 | -6.0% | 75,000,000 | 0.0% | 1.45% | -13.3% | ||
| IMGN | Buy | IMMUNOGEN INC | $67,592,000 | +309.2% | 15,020,490 | +332.8% | 1.39% | +277.8% |
| INSULET CORPnote 0.375% 9/0 | $66,018,000 | -13.4% | 57,581,000 | 0.0% | 1.36% | -20.1% | ||
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $63,137,000 | -12.7% | 3,244,434 | -1.2% | 1.30% | -19.4% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $62,867,000 | +203.7% | 3,512,123 | +68.3% | 1.30% | +180.1% |
| New | ACCOLADE INCnote 0.500% 4/0 | $59,134,000 | – | 92,624,000 | +100.0% | 1.22% | – | |
| NEVRO CORPnote 2.750% 4/0 | $57,724,000 | -11.7% | 61,000,000 | 0.0% | 1.19% | -18.5% | ||
| CMAX | CAREMAX INC | $57,576,000 | -52.7% | 15,861,090 | 0.0% | 1.19% | -56.4% | |
| New | GUARDANT HEALTH INCnote 11/1 | $56,684,000 | – | 89,036,000 | +100.0% | 1.17% | – | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $56,158,000 | +6.0% | 57,791,000 | 0.0% | 1.16% | -2.3% | ||
| COGT | Buy | COGENT BIOSCIENCES INC | $53,009,000 | +342.1% | 5,876,805 | +267.1% | 1.09% | +307.8% |
| LUNG | Sell | PULMONX CORP | $51,018,000 | -44.4% | 3,465,901 | -6.2% | 1.05% | -48.7% |
| ISEE | Buy | IVERIC BIO INC | $50,159,000 | -39.1% | 5,214,000 | +6.6% | 1.04% | -43.8% |
| CNC | Buy | CENTENE CORP DEL | $48,972,000 | +5.0% | 578,800 | +4.5% | 1.01% | -3.1% |
| New | OAK STR HEALTH INCnote 3/1 | $48,551,000 | – | 68,000,000 | +100.0% | 1.00% | – | |
| KURA | Sell | KURA ONCOLOGY INC | $48,153,000 | -32.2% | 2,627,000 | -40.5% | 0.99% | -37.5% |
| GKOS | Buy | GLAUKOS CORP | $47,215,000 | +121.0% | 1,039,514 | +181.3% | 0.97% | +103.8% |
| MOH | Buy | MOLINA HEALTHCARE INC | $46,695,000 | +3.7% | 167,000 | +23.7% | 0.96% | -4.4% |
| CYTK | Buy | CYTOKINETICS INC | $45,589,000 | +30.0% | 1,160,315 | +21.8% | 0.94% | +19.9% |
| MRUS | Buy | MERUS N V | $44,961,000 | +289.1% | 1,985,924 | +354.4% | 0.93% | +259.3% |
| New | DYNAVAX TECHNOLOGIES CORPnote 2.500% 5/1 | $44,735,000 | – | 30,000,000 | +100.0% | 0.92% | – | |
| New | LIVONGO HEALTH INCnote 0.875% 6/0 | $42,380,000 | – | 50,000,000 | +100.0% | 0.87% | – | |
| EOLS | Buy | EVOLUS INC | $42,140,000 | +205.5% | 3,632,751 | +195.5% | 0.87% | +182.1% |
| Buy | 1LIFE HEALTHCARE INCnote 3.000% 6/1 | $40,222,000 | +15.9% | 48,599,000 | +21.5% | 0.83% | +7.0% | |
| BKD | Buy | BROOKDALE SR LIVING INC | $39,010,000 | +2.9% | 8,592,461 | +59.7% | 0.80% | -5.1% |
| AERI | AERIE PHARMACEUTICALS INC | $35,213,000 | -17.6% | 4,695,020 | 0.0% | 0.73% | -24.0% | |
| New | PTC THERAPEUTICS INCnote 1.500% 9/1 | $33,439,000 | – | 32,000,000 | +100.0% | 0.69% | – | |
| EWTX | EDGEWISE THERAPEUTICS INC | $31,308,000 | -17.9% | 3,933,137 | 0.0% | 0.65% | -24.3% | |
| New | HILLEVAX INC | $28,614,000 | – | 2,617,948 | +100.0% | 0.59% | – | |
| PHVS | Sell | PHARVARIS N V | $26,307,000 | -8.0% | 1,190,343 | -24.5% | 0.54% | -15.0% |
| Buy | PTC THERAPEUTICS INCnote 3.000% 8/1 | $25,518,000 | +69.3% | 25,417,000 | +75.0% | 0.53% | +56.1% | |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $24,965,000 | -49.0% | 313,000 | -32.7% | 0.52% | -52.9% |
| NOVAVAX INCnote 3.750% 2/0 | $24,855,000 | -7.2% | 25,000,000 | 0.0% | 0.51% | -14.4% | ||
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $24,205,000 | -42.0% | 6,336,330 | -4.2% | 0.50% | -46.5% |
| Buy | SEMA4 HOLDINGS CORP | $23,749,000 | -44.1% | 18,848,488 | +36.1% | 0.49% | -48.4% | |
| BLU | Sell | BELLUS HEALTH INC NEW | $22,851,000 | -9.6% | 2,473,000 | -32.7% | 0.47% | -16.6% |
| ORGO | Sell | ORGANOGENESIS HLDGS INC | $21,705,000 | -66.3% | 4,447,740 | -47.4% | 0.45% | -68.9% |
| PHR | New | PHREESIA INC | $21,436,000 | – | 857,115 | +100.0% | 0.44% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $21,378,000 | – | 1,111,111 | +100.0% | 0.44% | – |
| AMED | New | AMEDISYS INC | $20,919,000 | – | 199,000 | +100.0% | 0.43% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $19,334,000 | – | 1,324,214 | +100.0% | 0.40% | – |
| INSM | Buy | INSMED INC | $18,941,000 | +164.6% | 960,484 | +215.4% | 0.39% | +144.4% |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $17,607,000 | -16.5% | 18,000,000 | 0.0% | 0.36% | -23.1% | ||
| RVMD | REVOLUTION MEDICINES INC | $17,377,000 | -23.6% | 891,587 | 0.0% | 0.36% | -29.5% | |
| Buy | THE ONCOLOGY INSTITUTE INC | $17,118,000 | -46.7% | 3,383,099 | +2.6% | 0.35% | -50.8% | |
| PCRX | New | PACIRA BIOSCIENCES INC | $17,024,000 | – | 292,000 | +100.0% | 0.35% | – |
| ATEC | Sell | ALPHATEC HLDGS INC | $15,830,000 | -61.7% | 2,420,547 | -32.7% | 0.33% | -64.6% |
| ANAB | New | ANAPTYSBIO INC | $15,672,000 | – | 772,000 | +100.0% | 0.32% | – |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,504,000 | -0.3% | 1,600,000 | 0.0% | 0.32% | -8.0% | ||
| HEALTH CATALYST INCnote 2.500% 4/1 | $13,452,000 | -21.7% | 15,000,000 | 0.0% | 0.28% | -27.9% | ||
| INZY | Buy | INOZYME PHARMA INC | $12,862,000 | +34.1% | 2,696,372 | +15.0% | 0.26% | +23.8% |
| PROF | PROFOUND MED CORP | $12,494,000 | -19.0% | 1,713,797 | 0.0% | 0.26% | -25.2% | |
| KZR | New | KEZAR LIFE SCIENCES INC | $11,735,000 | – | 1,419,000 | +100.0% | 0.24% | – |
| LRMR | LARIMAR THERAPEUTICS INC | $11,427,000 | -51.6% | 5,830,249 | 0.0% | 0.24% | -55.3% | |
| TGTX | New | TG THERAPEUTICS INC | $11,379,000 | – | 2,677,500 | +100.0% | 0.24% | – |
| ALEC | ALECTOR INC | $10,721,000 | -28.7% | 1,055,192 | 0.0% | 0.22% | -34.2% | |
| FHTX | Buy | FOGHORN THERAPEUTICS INC | $10,574,000 | +190.7% | 777,525 | +225.5% | 0.22% | +169.1% |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $9,890,000 | -0.1% | 999,999 | 0.0% | 0.20% | -7.7% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $9,900,000 | +0.6% | 999,999 | 0.0% | 0.20% | -7.3% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,840,000 | +0.2% | 1,000,000 | 0.0% | 0.20% | -7.7% | |
| MTAC | MEDTECH ACQUISITION CORP | $9,845,000 | +0.5% | 999,999 | 0.0% | 0.20% | -7.3% | |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,770,000 | -0.4% | 1,000,000 | 0.0% | 0.20% | -7.8% | |
| New | PEPGEN INC | $9,470,000 | – | 953,626 | +100.0% | 0.20% | – | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $7,448,000 | +0.8% | 750,000 | 0.0% | 0.15% | -6.7% | |
| NKTX | New | NKARTA INC | $7,392,000 | – | 600,000 | +100.0% | 0.15% | – |
| IGNY | IGNYTE ACQUISITION CORP | $7,149,000 | +0.2% | 725,000 | 0.0% | 0.15% | -7.5% | |
| APEN | APOLLO ENDOSURGERY INC | $6,388,000 | -39.7% | 1,750,000 | 0.0% | 0.13% | -44.3% | |
| XILIO THERAPEUTICS INC | $6,070,000 | -58.7% | 2,078,692 | 0.0% | 0.12% | -62.0% | ||
| OM | OUTSET MED INC | $5,953,000 | -67.3% | 400,622 | 0.0% | 0.12% | -69.8% | |
| New | BENEFITFOCUS INCnote 1.250%12/1 | $5,907,000 | – | 6,500,000 | +100.0% | 0.12% | – | |
| GRAY | GRAYBUG VISION INC | $5,757,000 | -11.4% | 5,281,713 | 0.0% | 0.12% | -17.9% | |
| Buy | AN2 THERAPEUTICS INC | $5,553,000 | -36.9% | 716,538 | +22.7% | 0.12% | -41.6% | |
| New | NEOGENOMICS INCnote 1.250% 5/0 | $5,443,000 | – | 6,500,000 | +100.0% | 0.11% | – | |
| OHPA | ORION ACQUISITION CORP | $4,900,000 | +0.3% | 500,000 | 0.0% | 0.10% | -7.3% | |
| NYXOAH S A | $4,188,000 | -51.9% | 455,262 | 0.0% | 0.09% | -55.9% | ||
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,060,000 | -17.9% | 6,949,416 | 0.0% | 0.08% | -24.3% | |
| ONCR | ONCORUS INC | $3,968,000 | -29.2% | 3,148,977 | 0.0% | 0.08% | -34.4% | |
| HOWL | WEREWOLF THERAPEUTICS INC | $3,919,000 | -7.0% | 958,125 | 0.0% | 0.08% | -13.8% | |
| QSI | QUANTUM SI INC | $3,248,000 | -50.4% | 1,400,000 | 0.0% | 0.07% | -54.1% | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $3,153,000 | -71.6% | 250,000 | -74.6% | 0.06% | -73.8% |
| AFIB | ACUTUS MED INC | $2,966,000 | -19.4% | 2,648,386 | 0.0% | 0.06% | -25.6% | |
| ANNX | ANNEXON INC | $2,201,000 | +38.1% | 583,913 | 0.0% | 0.04% | +25.0% | |
| DCTH | DELCATH SYS INC | $1,995,000 | -37.7% | 500,000 | 0.0% | 0.04% | -43.1% | |
| ETNB | New | 89BIO INC | $1,630,000 | – | 506,100 | +100.0% | 0.03% | – |
| MDVL | Sell | MEDAVAIL HOLDINGS INC | $1,280,000 | +15.3% | 836,626 | -26.8% | 0.03% | +4.0% |
| RYTM | RHYTHM PHARMACEUTICALS INC | $1,208,000 | -64.0% | 291,005 | 0.0% | 0.02% | -66.7% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $625,000 | -56.5% | 1,250,000 | 0.0% | 0.01% | -59.4% | ||
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $600,000 | -31.8% | 1,000,000 | 0.0% | 0.01% | -40.0% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $484,000 | -62.1% | 672,000 | 0.0% | 0.01% | -65.5% | |
| CABA | CABALETTA BIO INC | $492,000 | -47.8% | 464,252 | 0.0% | 0.01% | -52.4% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $296,000 | -60.4% | 733,333 | 0.0% | 0.01% | -64.7% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $188,000 | -50.9% | 333,333 | 0.0% | 0.00% | -55.6% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $76,000 | -42.4% | 362,500 | 0.0% | 0.00% | -33.3% | |
| SOMALOGIC INC*w exp 08/31/202 | $91,000 | -64.6% | 120,000 | 0.0% | 0.00% | -66.7% | ||
| SURROZEN INC*w exp 08/01/203 | $32,000 | -23.8% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $35,000 | -61.1% | 500,000 | 0.0% | 0.00% | -50.0% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $47,000 | -65.2% | 166,666 | 0.0% | 0.00% | -66.7% | |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $28,000 | -67.1% | 333,333 | 0.0% | 0.00% | -50.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $49,000 | -45.6% | 200,000 | 0.0% | 0.00% | -50.0% | |
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $33,000 | -72.5% | 333,333 | 0.0% | 0.00% | -66.7% | |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -470 | -100.0% | 0.00% | – |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $22,000 | -64.5% | 333,333 | 0.0% | 0.00% | -100.0% | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | 1 | 0.0% | 0.00% | – | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $11,000 | -71.8% | 125,000 | 0.0% | 0.00% | -100.0% | |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $19,000 | -76.8% | 250,000 | 0.0% | 0.00% | -100.0% | |
| WINT | WINDTREE THERAPEUTICS INC | $8,000 | -65.2% | 20,148 | 0.0% | 0.00% | -100.0% | |
| BCAB | Exit | BIOATLA INC | $0 | – | -289,002 | -100.0% | -0.03% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -391,115 | -100.0% | -0.04% | – |
| Exit | NEOGENOMICS INCnote 0.250% 1/1 | $0 | – | -2,500,000 | -100.0% | -0.04% | – | |
| GKOS | Exit | GLAUKOS CORPcall | $0 | – | -45,200 | -100.0% | -0.06% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -375,585 | -100.0% | -0.09% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -1,379,310 | -100.0% | -0.12% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.14% | – | |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -2,345,959 | -100.0% | -0.16% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -830,472 | -100.0% | -0.27% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -249,988 | -100.0% | -0.32% | – |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -18,000,000 | -100.0% | -0.32% | – | |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -1,012,000 | -100.0% | -0.37% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -3,577,233 | -100.0% | -0.42% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -979,106 | -100.0% | -0.42% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -270,000 | -100.0% | -0.50% | – |
| Exit | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $0 | – | -80,000,000 | -100.0% | -1.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.